Precision Treatment to Promote Smoking Cessation and Survival in Oncology Patients (NCT07166120)
🩺 Plain-English Summary (8th-Grade Level)
This study evaluates the feasibility and preliminary effects of precision tobacco treatment, compared to usual care, on promoting tobacco treatment in oncology patients and providers in the oncology care setting. The precision treatment intervention includes personalized tobacco treatment recommendations using the patient's clinical, genetic, and biomarker information. This intervention may increase patient receipt of tobacco treatment, patient medication use, and patient smoking abstinence at 6 months.
Who can join: To join this study, participants generally need to meet the listed inclusion criteria (6 items) and avoid the listed exclusions (5 items).
Location: John Cochran Veteran's Affairs Medical Center — St Louis, Missouri
Age range: 18 Years to 89 Years
🧪 Interventions in This Study
- Usual care (BEHAVIORAL)
- Precision treatment (BEHAVIORAL)
📋 "Do I Qualify?" — 1-Minute Self Screener
Instant ChecklistCheck every box below. If you can check all of them, you may meet the study's basic screening requirements (final eligibility is confirmed by the site team).
Usually NOT eligible if any of the following apply:
- Exclusion Criteria for Patients:
- Active use of smoking cessation medication (within the past 30 days)
- Receipt of smoking cessation medication or prescription for smoking cessation medication (within the past 30 days)
- Having a contradiction for cNRT or varenicline (allergic reactions, current cardiac problems, pregnancy)
- Patients who were deemed by the investigator to be ineligible for participation in the trial
🔍 Extracted verbatim from the official NIH eligibility criteria. Always confirm with the study coordinator.
📍 All Participating Trial Locations (2 Sites)
- John Cochran Veteran's Affairs Medical Center — St Louis, Missouri
- Washington University School of Medicine — St Louis, Missouri
📞 Contact the Study Coordinator
Phone: (314) 362-3932
Email: li-shiun@wustl.edu
Coordinator details come directly from the registered NIH protocol. Confirm the study is still recruiting before traveling.
💰 Cost, Insurance & Patient Rights
- 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
- Routine Patient Care: Under federal law (ACA § 2709) and many state statutes, routine care costs are covered during participation.
- Voluntary Participation: You may withdraw at any time without affecting your standard medical care.
More studies in Smoking Cessation
- Adaptive Mobile Interventions to Reduce Cancer Risk Behaviors — Baltimore, Maryland
- Trauma-Informed Care for Smoking Cessation for Pregnancy — San Francisco, California
- Acceptability of Mobile Applications (Apps) to Enhance Smoking Cessation in a Clinical Tobacco Treatment Program - A Pilot Study — Houston, Texas
- Telephone All Nations Breath of Life — Bethlehem, Pennsylvania
- Quitxt Mobile Text Messaging Cessation Research Study — San Antonio, Texas
Explore by condition: All Smoking Cessation clinical trials
💡 How to Participate
- Check the checklist above to see if you may qualify.
- Contact the study coordinator using the phone/email above.
- Ask about the visit schedule, what is covered at no cost, and any travel support.
- Confirm with your own doctor before making a decision.